Search Share Prices
AZN Share Price - AstraZeneca and Merck’s Lynparza drug approved by US FDA for pancreatic cancer
“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...
Will these 3 FTSE 100 shares make 20% gains in 2020? Barclays, Taylor Wimpey and AstraZeneca
The performances of FTSE 100 shares Barclays PLC (LON:BARC) (BARC.L), Taylor Wimpey plc (LON:TW) (TW.L) and AstraZeneca plc (LON:AZN) (AZN.L) in 2019 has been strong. All three stocks have made gains ...
AstraZeneca and Daiichi Sankyo's breast cancer treatment gets US approval
AstraZeneca and Daiichi Sankyo are exploring the further potential of Enhertu in HER2-breast cancer with three ongoing Phase III trials The US Food and Drug Administration (FDA) has approved Enhertu, ...
Premarket London: Shell Raises Oil Output Forecast, Sees Write-Offs
Gasoline marketing margins will be down due to seasonal effects and crude price movements. AstraZeneca (LON:AZN) said it will sell the commercial rights to its breast and prostate cancer drugs ...
Flu Vaccine Market Study of Revenue Details, Threats in the Target Market and Forecast By 2023
Get Sample Copy of this Report @https://www.bigmarketresearch.com/request-sample/3312721?utm_source=Geeta-MRA By Top Market Players: CSL CSL, -0.76%, GSK GSK, +0.51%, Sanofi Pasteur (epa:SAN), Mylan ...